Helius Medical Tech Analyst Ratings
Helius Medical Tech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/20/2022 | 323.73% | Maxim Group | → $1 | Initiates Coverage On | → Buy |
| 08/23/2022 | 2018.64% | Roth Capital | → $5 | Initiates Coverage On | → Buy |
| 11/15/2021 | — | Noble Capital Markets | Downgrades | Outperform → Market Perform | |
| 03/24/2021 | 8374.58% | Noble Capital Markets | → $20 | Initiates Coverage On | → Outperform |
| 04/16/2019 | — | BTIG | Downgrades | Buy → Neutral | |
| 04/11/2019 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 03/06/2019 | — | Oppenheimer | Initiates Coverage On | → Outperform | |
| 11/20/2018 | 5832.2% | BTIG | → $14 | Upgrades | Neutral → Buy |
| 06/19/2018 | — | BTIG | Downgrades | Buy → Neutral | |
| 05/17/2018 | 5832.2% | BTIG | → $14 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
|---|---|---|---|---|---|
| 2022 年 12 月 20 日 | 323.73% | Maxim 集团 | → 1 美元 | 开启覆盖范围 | → 购买 |
| 08/23/2022 | 2018.64% | 罗斯资本 | → 5 美元 | 开启覆盖范围 | → 购买 |
| 11/15/2021 | — | 诺布尔资本市场 | 降级 | 跑赢大盘 → 市场表现 | |
| 2021 年 3 月 24 日 | 8374.58% | 诺布尔资本市场 | → 20 美元 | 开启覆盖范围 | → 跑赢大盘 |
| 04/16/2019 | — | BTIG | 降级 | 买入 → 中性 | |
| 04/11/2019 | — | 奥本海默 | 降级 | 跑赢大盘 → 表现 | |
| 03/06/2019 | — | 奥本海默 | 开启覆盖范围 | → 跑赢大盘 | |
| 11/20/2018 | 5832.2% | BTIG | → 14 美元 | 升级 | 中性 → 买入 |
| 06/19/2018 | — | BTIG | 降级 | 买入 → 中性 | |
| 05/17/2018 | 5832.2% | BTIG | → 14 美元 | 开启覆盖范围 | → 购买 |
What is the target price for Helius Medical Tech (HSDT)?
Helius Medical Tech（HSDT）的目标价格是多少？
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on December 20, 2022. The analyst firm set a price target for $1.00 expecting HSDT to rise to within 12 months (a possible 323.73% upside). 2 analyst firms have reported ratings in the last year.
Maxim集团于2022年12月20日公布了Helius Medical Tech（纳斯达克股票代码：HSDT）的最新目标股价。这家分析公司将目标价设定为1.00美元，预计HSDT将在12个月内升至12个月（可能上涨323.73％）。去年，有两家分析公司公布了评级。
What is the most recent analyst rating for Helius Medical Tech (HSDT)?
Helius Medical Tech（HSDT）的最新分析师评级是多少？
The latest analyst rating for Helius Medical Tech (NASDAQ: HSDT) was provided by Maxim Group, and Helius Medical Tech initiated their buy rating.
Helius Medical Tech（纳斯达克股票代码：HSDT）的最新分析师评级由Maxim集团提供，Helius Medical Tech启动了买入评级。
When is the next analyst rating going to be posted or updated for Helius Medical Tech (HSDT)?
Helius Medical Tech（HSDT）的下一个分析师评级将在何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Helius Medical Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Helius Medical Tech was filed on December 20, 2022 so you should expect the next rating to be made available sometime around December 20, 2023.
分析师在进行了广泛的研究后得出了股票评级，包括浏览公开财务报表，与Helius Medical Tech的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月这样做一次，因此每家公司每年应该获得4次评级。Helius Medical Tech的最新评级是在2022年12月20日提交的，因此您应该预计下一个评级将在2023年12月20日左右公布。
Is the Analyst Rating Helius Medical Tech (HSDT) correct?
分析师对Helius Medical Tech（HSDT）的评级是否正确？
While ratings are subjective and will change, the latest Helius Medical Tech (HSDT) rating was a initiated with a price target of $0.00 to $1.00. The current price Helius Medical Tech (HSDT) is trading at is $0.24, which is within the analyst's predicted range.
虽然评级是主观的，而且会发生变化，但最新的Helius Medical Tech（HSDT）评级是最初的，目标价为0.00美元至1.00美元。Helius Medical Tech（HSDT）目前的交易价格为0.24美元，在分析师的预测区间内。